IRADIMED CORPORATION Statistics
Total Valuation
IRMD has a market cap or net worth of $1.09 billion. The enterprise value is $1.03 billion.
| Market Cap | 1.09B |
| Enterprise Value | 1.03B |
Important Dates
The last earnings date was Friday, May 1, 2026, before market open.
| Earnings Date | May 1, 2026 |
| Ex-Dividend Date | May 15, 2026 |
Share Statistics
IRMD has 12.78 million shares outstanding. The number of shares has increased by 0.48% in one year.
| Current Share Class | 12.78M |
| Shares Outstanding | 12.78M |
| Shares Change (YoY) | +0.48% |
| Shares Change (QoQ) | -0.04% |
| Owned by Insiders (%) | 35.06% |
| Owned by Institutions (%) | 60.09% |
| Float | 8.30M |
Valuation Ratios
The trailing PE ratio is 46.60 and the forward PE ratio is 42.74.
| PE Ratio | 46.60 |
| Forward PE | 42.74 |
| PS Ratio | 12.63 |
| Forward PS | 15.32 |
| PB Ratio | 11.06 |
| P/TBV Ratio | 11.45 |
| P/FCF Ratio | 44.54 |
| P/OCF Ratio | 37.66 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 35.18, with an EV/FCF ratio of 42.23.
| EV / Earnings | 43.78 |
| EV / Sales | 11.98 |
| EV / EBITDA | 35.18 |
| EV / EBIT | 36.98 |
| EV / FCF | 42.23 |
Financial Position
The company has a current ratio of 7.13
| Current Ratio | 7.13 |
| Quick Ratio | 5.76 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 25.04% and return on invested capital (ROIC) is 51.09%.
| Return on Equity (ROE) | 25.04% |
| Return on Assets (ROA) | 16.17% |
| Return on Invested Capital (ROIC) | 51.09% |
| Return on Capital Employed (ROCE) | 27.33% |
| Weighted Average Cost of Capital (WACC) | 9.27% |
| Revenue Per Employee | $519,771 |
| Profits Per Employee | $142,235 |
| Employee Count | 166 |
| Asset Turnover | 0.80 |
| Inventory Turnover | 1.78 |
Taxes
In the past 12 months, IRMD has paid $6.57 million in taxes.
| Income Tax | 6.57M |
| Effective Tax Rate | 21.78% |
Stock Price Statistics
The stock price has increased by +62.20% in the last 52 weeks. The beta is 0.91, so IRMD's price volatility has been similar to the market average.
| Beta (5Y) | 0.91 |
| 52-Week Price Change | +62.20% |
| 50-Day Moving Average | 93.83 |
| 200-Day Moving Average | 87.22 |
| Relative Strength Index (RSI) | 38.87 |
| Average Volume (20 Days) | 109,307 |
Short Selling Information
The latest short interest is 540,183, so 4.23% of the outstanding shares have been sold short.
| Short Interest | 540,183 |
| Short Previous Month | 499,380 |
| Short % of Shares Out | 4.23% |
| Short % of Float | 6.51% |
| Short Ratio (days to cover) | 5.57 |
Income Statement
In the last 12 months, IRMD had revenue of $86.28 million and earned $23.61 million in profits. Earnings per share was $1.83.
| Revenue | 86.28M |
| Gross Profit | 66.30M |
| Operating Income | 27.95M |
| Pretax Income | 30.19M |
| Net Income | 23.61M |
| EBITDA | 29.38M |
| EBIT | 27.95M |
| Earnings Per Share (EPS) | $1.83 |
Balance Sheet
The company has $56.37 million in cash and n/a in debt, with a net cash position of $56.37 million or $4.41 per share.
| Cash & Cash Equivalents | 56.37M |
| Total Debt | n/a |
| Net Cash | 56.37M |
| Net Cash Per Share | $4.41 |
| Equity (Book Value) | 98.51M |
| Book Value Per Share | 7.71 |
| Working Capital | 74.30M |
Cash Flow
In the last 12 months, operating cash flow was $28.95 million and capital expenditures -$4.47 million, giving a free cash flow of $24.47 million.
| Operating Cash Flow | 28.95M |
| Capital Expenditures | -4.47M |
| Depreciation & Amortization | 1.43M |
| Net Borrowing | n/a |
| Free Cash Flow | 24.47M |
| FCF Per Share | $1.91 |
Margins
Gross margin is 76.84%, with operating and profit margins of 32.40% and 27.36%.
| Gross Margin | 76.84% |
| Operating Margin | 32.40% |
| Pretax Margin | 34.98% |
| Profit Margin | 27.36% |
| EBITDA Margin | 34.05% |
| EBIT Margin | 32.40% |
| FCF Margin | 28.37% |
Dividends & Yields
This stock pays an annual dividend of $0.80, which amounts to a dividend yield of 0.94%.
| Dividend Per Share | $0.80 |
| Dividend Yield | 0.94% |
| Dividend Growth (YoY) | 93.75% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 67.77% |
| Buyback Yield | -0.48% |
| Shareholder Yield | 0.46% |
| Earnings Yield | 2.17% |
| FCF Yield | 2.25% |
Analyst Forecast
The average price target for IRMD is $116.00, which is 36.04% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $116.00 |
| Price Target Difference | 36.04% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 12.17% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IRMD has an Altman Z-Score of 40.06 and a Piotroski F-Score of 5.
| Altman Z-Score | 40.06 |
| Piotroski F-Score | 5 |